CK Life Sciences: No Change in Share Capital for March 2026; Public Float Meets 25% Rule

Bulletin Express

Apr 02

CK Life Sciences Int'l. (Holdings) Inc. filed its Monthly Return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained static during the month.

• Authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 1.50 billion. No increase or decrease was recorded.

• Issued share capital totalled 9.61 billion ordinary shares, unchanged from the previous month. The company held no treasury shares.

• No movements were reported under share option schemes, warrants, convertibles, or other share-related arrangements.

• CK Life Sciences confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least 25% of issued shares in public hands as of 31 March 2026.

The filing, signed by Company Secretary Eirene Yeung on 2 April 2026, indicates stable capital structure and adherence to Hong Kong Listing Rule obligations during the reporting month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1131066654"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1131066654\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1131066654?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131066654","market":"us","top_or_hot":-1,"title":"CK Life Sciences: No Change in Share Capital for March 2026; Public Float Meets 25% Rule","media":"Bulletin Express","content":"<p>CK Life Sciences Int'l. (Holdings) Inc. filed its Monthly Return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained static during the month.</p>\n<p>• Authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 1.50 billion. No increase or decrease was recorded.</p>\n<p>• Issued share capital totalled 9.61 billion ordinary shares, unchanged from the previous month. The company held no treasury shares.</p>\n<p>• No movements were reported under share option schemes, warrants, convertibles, or other share-related arrangements.</p>\n<p>• CK Life Sciences confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least 25% of issued shares in public hands as of 31 March 2026.</p>\n<p>The filing, signed by Company Secretary Eirene Yeung on 2 April 2026, indicates stable capital structure and adherence to Hong Kong Listing Rule obligations during the reporting month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CK Life Sciences: No Change in Share Capital for March 2026; Public Float Meets 25% Rule</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCK Life Sciences: No Change in Share Capital for March 2026; Public Float Meets 25% Rule\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CK Life Sciences Int'l. (Holdings) Inc. filed its Monthly Return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained static during the month.</p>\n<p>• Authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 1.50 billion. No increase or decrease was recorded.</p>\n<p>• Issued share capital totalled 9.61 billion ordinary shares, unchanged from the previous month. The company held no treasury shares.</p>\n<p>• No movements were reported under share option schemes, warrants, convertibles, or other share-related arrangements.</p>\n<p>• CK Life Sciences confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least 25% of issued shares in public hands as of 31 March 2026.</p>\n<p>The filing, signed by Company Secretary Eirene Yeung on 2 April 2026, indicates stable capital structure and adherence to Hong Kong Listing Rule obligations during the reporting month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00775","symbol_name":"长江生命科技","start_time":0,"source_url":"","article_id":"1131066654","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131066654","pubTimestamp":1775126591,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CK Life Sciences Int'l. (Holdings) Inc. filed its Monthly Return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained static during the month. •...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00775":"长江生命科技"},"translate_title":"长江生命科技：2026年3月股本无变化；公众持股量符合25%规则","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00775":1},"content_text":"CK Life Sciences Int'l. (Holdings) Inc. filed its Monthly Return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained static during the month.\n• Authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 1.50 billion. No increase or decrease was recorded.\n• Issued share capital totalled 9.61 billion ordinary shares, unchanged from the previous month. The company held no treasury shares.\n• No movements were reported under share option schemes, warrants, convertibles, or other share-related arrangements.\n• CK Life Sciences confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least 25% of issued shares in public hands as of 31 March 2026.\nThe filing, signed by Company Secretary Eirene Yeung on 2 April 2026, indicates stable capital structure and adherence to Hong Kong Listing Rule obligations during the reporting month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}